HomeHealthcare & Life SciencesPharmaceuticals Bioidentical Hormones Market

India Bioidentical Hormones Market Size & Outlook, 2025-2033


India Bioidentical Hormones Market Insights

  • As per Reed Intelligence insights, the India Bioidentical Hormones Market stood at USD 170.53 Million in 2024 and is anticipated to grow to USD 278.9 Million by 2033.
  • The India market is expected to advance at a CAGR of 5.63% from 2026 through 2033.
  • In 2024, Estrogens accounted for the highest share of the By Type market size.
  • During the forecast period, Testosterone is set to register the highest growth, making it the most lucrative By Type segment.

Other Key Findings


  • As of 2024, India held 4.74% of the global Bioidentical Hormones Market size.
  • By 2033, United States is anticipated to capture the largest share of the global Bioidentical Hormones Market.
  • In Asia Pacific, China is expected to lead the regional Bioidentical Hormones Market size by 2033.
  • Japan will remain the fastest-growing market in Asia Pacific, reaching USD 202.29 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 170.53 Million
Market Size In 2033 USD 278.9 Million
Largest segment Estrogens
Units Revenue in USD Million
CAGR 5.63% (2025-2033)
Segmnetation Covered
By Type
  1. Estrogens
  2. Progesterone
  3. Testosterone
  4. Others
By Form
  1. Tablets and capsules
  2. Creams and gels
  3. Injectables
  4. Patches and implants
  5. Others
By Route of Administration
  1. Oral
  2. Parenteral
  3. Topical
By End-use
  1. Hospitals
  2. Gynecology clinics
  3. Research laboratories
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports